Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,285 across all filing types
Latest filing 2020-04-23 Report Publication Anno…
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
2020年第一季度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (337 characters) indicating that the company's 2020 first quarter report has been published and is available on the official disclosure website. It explicitly states that the full quarterly report has been disclosed elsewhere and advises investors to review it. There is no substantive financial data or analysis within this text itself, only a notification of the report's availability. According to the 'MENU VS MEAL' rule, such a brief notice about the report's publication is classified as a Report Publication Announcement (RPA), not the report itself (IR).
2020-04-23 Chinese
2019年年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2019 Annual General Meeting (AGM) of Tianjin Ruipu Biotechnology Co., Ltd. It details the procedures of the AGM, the qualifications of attendees, the voting process, and the voting results on various agenda items including approval of the 2019 annual report, financial statements, profit distribution, and election of directors. The document is not the annual report itself but a legal opinion on the AGM proceedings and voting results. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting outcomes of the AGM. The document length is over 6000 characters and contains detailed voting results, supporting this classification with high confidence.
2020-04-23 Chinese
第四届董事会第十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of Tianjin Ruipu Biotechnology Co., Ltd. It includes approval of the company's 2020 first quarter report, election of a new board committee member, and approval of an investment project by a subsidiary. The document is titled as a board meeting resolution announcement and contains voting results for each agenda item. It does not contain the full financial report itself but references that the full 2020 first quarter report is disclosed on the official regulatory website. The document length is short (1439 characters) and serves as an announcement of board decisions and approvals rather than the report itself. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management and related board resolutions.
2020-04-23 Chinese
关于获得专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Tianjin Ruipu Biological Technology Co., Ltd. regarding the receipt of three invention patent certificates issued by the National Intellectual Property Office. It details the patent names, application numbers, and the significance of these patents to the company's R&D and innovation capabilities. There is no financial data, no mention of financial results, no regulatory certifications, or meeting-related information. The document is an announcement about intellectual property achievements, which does not fit into financial reports, management changes, or other specific categories. It is a regulatory announcement about patents, best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2020-04-09 Chinese
2020年第一季度业绩预告
Earnings Release Classification · 95% confidence The document is a quarterly earnings forecast (业绩预告) for the first quarter of 2020, providing estimated net profit figures and growth percentages compared to the previous year. It explicitly states that the forecast is unaudited and that detailed data will be disclosed in the official quarterly report later. The document is short (1562 characters) and serves as an initial earnings announcement rather than a full interim report containing actual financial statements or substantive financial data. Therefore, it fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly financial results with key highlights only. Q1 2020
2020-04-09 Chinese
更正公告
AGM Information Classification · 95% confidence The document is a correction announcement related to previously disclosed notices about the 2019 Annual General Meeting (AGM) of Tianjin Ruipu Biotechnology Co., Ltd. It references multiple agenda items for the 2019 Annual Report, Board and Supervisory reports, audited financial reports, profit distribution, and other related proposals to be voted on at the AGM. The document includes details about voting proposals and an authorization letter for proxy voting. It also corrects a previous announcement about a supervisory board meeting resolution. The document does not contain the actual annual report or financial statements but rather corrections to announcements and voting materials related to the AGM. Therefore, it is best classified as AGM Information (AGM-R).
2020-04-03 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.